Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LEGN Legend Biotech

Trading 05-20 09:42:25 EDT

45.55

+0.39

+0.86%

High45.56	Low45.13	Vol17.61K
Open45.42	D1 Closing45.16	Amplitude0.95%
Mkt Cap8.30B	Tradable Cap3.63B	Total Shares182.28M
T/O799.79K	T/O Rate0.02%	Tradable Shares79.76M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"LEGN","market":"US","secType":"STK","nameCN":"Legend Biotech","latestPrice":45.548,"timestamp":1716212539792,"preClose":45.16,"halted":0,"volume":17607,"delay":0,"floatShares":79764850,"shares":182283494,"eps":-2.584684,"marketStatus":"Trading","change":0.388,"latestTime":"05-20 09:42:25 EDT","open":45.42,"high":45.56,"low":45.13,"amount":799791.918192,"amplitude":0.009522,"askPrice":45.54,"askSize":273,"bidPrice":45.4,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-2.584684,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1716235200000},"marketStatusCode":2,"adr":0,"adrRate":2,"listingDate":1591329600000,"exchange":"NASDAQ","adjPreClose":45.16,"postHourTrading":{"tag":"盘后","latestPrice":45.16,"preClose":45.16,"latestTime":"19:09 EDT","volume":1959,"amount":88444.34,"timestamp":1715987346102},"volumeRatio":0.517137,"overnightSupported":true},"requestUrl":"/m/hq/s/LEGN/tweets","defaultTab":"tweets","newsList":[{"id":"2435672114","title":"AbCellera: If You Build It, Will They Come? Fresh Impetus Required","url":"https://stock-news.laohu8.com/highlight/detail?id=2435672114","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435672114?lang=en_us&edition=fundamental","pubTime":"2024-05-16 20:39","pubTimestamp":1715863140,"startTime":"0","endTime":"0","summary":"AbCellera's valuation has shrunk by 80% since its IPO due to the withdrawal of its COVID antiviral, bamlanivimab.The company reported Q1 2024 revenues of $10 million, down from $12.2 million in the pr","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1501249755/image_1501249755.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1501249755/image_1501249755.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4693825-abcellera-if-you-build-it-will-they-come-fresh-impetus-required-abcl-stock","is_publish_highlight":false,"gpt_icon":0},{"id":"2435660634","title":"Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Singular Genomics Systems (OMIC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435660634","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435660634?lang=en_us&edition=fundamental","pubTime":"2024-05-15 20:01","pubTimestamp":1715774482,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Daré Bioscience (DARE – Research Report), Legend Bio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dare-bioscience-dare-legend-biotech-legn-and-singular-genomics-systems-omic?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dare-bioscience-dare-legend-biotech-legn-and-singular-genomics-systems-omic?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435513067","title":"Legend Biotech's Carvykti Faces Stiff Challenges Despite Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2435513067","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435513067?lang=en_us&edition=fundamental","pubTime":"2024-05-14 20:45","pubTimestamp":1715690700,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation reported lower-than-expected Q1 earnings, reflecting struggles in Carvykti’s revenue generation despite strong market potential.Carvykti, despite superior indications compar","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1433912402/image_1433912402.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1433912402/image_1433912402.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4693033-legend-biotech-carvykti-faces-stiff-challenges-despite-advances","is_publish_highlight":false,"gpt_icon":0},{"id":"2435359770","title":"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Green Thumb Industries (OtherGTBIF) and OmniAb (OABI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435359770","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435359770?lang=en_us&edition=fundamental","pubTime":"2024-05-14 20:10","pubTimestamp":1715688624,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Legend Biotech (LEGN – Research Report), Green Thumb...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-green-thumb-industries-othergtbif-and-omniab-oabi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-green-thumb-industries-othergtbif-and-omniab-oabi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435592822","title":"Scotiabank Sticks to Their Buy Rating for Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435592822","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435592822?lang=en_us&edition=fundamental","pubTime":"2024-05-14 19:37","pubTimestamp":1715686651,"startTime":"0","endTime":"0","summary":"Scotiabank analyst George Farmer maintained a Buy rating on Legend Biotech (LEGN – Research Report) today and set a price target of $65.00. The com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/scotiabank-sticks-to-their-buy-rating-for-legend-biotech-legn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/scotiabank-sticks-to-their-buy-rating-for-legend-biotech-legn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435594554","title":"Buy Rating for Legend Biotech Anchored by Carvykti’s Growth and Market Penetration Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2435594554","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435594554?lang=en_us&edition=fundamental","pubTime":"2024-05-14 19:25","pubTimestamp":1715685958,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Kostas Biliouris from...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-for-legend-biotech-anchored-by-carvyktis-growth-and-market-penetration-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-for-legend-biotech-anchored-by-carvyktis-growth-and-market-penetration-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435596483","title":"Analysts Are Bullish on Top Healthcare Stocks: Legend Biotech (LEGN), Oculis Holding (OCS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435596483","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435596483?lang=en_us&edition=fundamental","pubTime":"2024-05-14 18:30","pubTimestamp":1715682615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Legend Biotech (LEGN – Research Report), Oculis Hold...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-legend-biotech-legn-oculis-holding-ocs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-legend-biotech-legn-oculis-holding-ocs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435656897","title":"U.S. RESEARCH ROUNDUP- Akoya Biosciences, Boston Beer Company, Victory Capital Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2435656897","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2435656897?lang=en_us&edition=fundamental","pubTime":"2024-05-14 15:20","pubTimestamp":1715671208,"startTime":"0","endTime":"0","summary":"May 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Akoya Biosciences, Boston Beer Company and Victory Capital Holdin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435566663","title":"Legend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2435566663","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2435566663?lang=en_us&edition=fundamental","pubTime":"2024-05-14 15:01","pubTimestamp":1715670069,"startTime":"0","endTime":"0","summary":"CARVYKTI Net Trade Sales: $157 million in Q1 2024, a 100% increase year-over-year.Total Revenue: $94 million in Q1 2024, including $78.5 million from CARVYKTI and $12.2 million in license revenue.Net Loss: $59.8 million in Q1 2024, or -$0.16 per share.Collaboration Cost of Revenue: $49.1 million in Q1 2024.Cost of License and Other Revenue: $5.6 million in Q1 2024.Research and Development Expenses: $101 million in Q1 2024.Selling and Distribution Expenses: $24.2 million in Q1 2024.Cash Balance: $1.3 billion as of March 31, 2024.GuruFocus has detected 4 Warning Signs with LEGN.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Legend Biotech Corp  has a strong cash balance of $1.3 billion, providing financial stability and supporting ongoing production expansion and operational activities.The company is expanding production capacity, including doubling the processing capacity at the Raritan, New Jersey facility and progressing towards com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/legend-biotech-corp-legn-q1-070109922.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435553546","title":"Q1 2024 Legend Biotech Corp Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2435553546","media":"Thomson Reuters StreetEvents","top":-1,"share":"https://ttm.financial/m/news/2435553546?lang=en_us&edition=fundamental","pubTime":"2024-05-14 12:20","pubTimestamp":1715660401,"startTime":"0","endTime":"0","summary":"Guowei Fang; Chief Scientific Officer & Head of Business Development; Legend Biotech Corporation. Steven J. Gavel; SVP of Commercial Development, US & Europe; Legend Biotech Corporation. Ying Huang; CEO & Director; Legend Biotech Corporation. Ashwani Verma; Director of Americas Equity Research & US Specialty Pharma Analyst; UBS Investment Bank, Research Division. Dingding Shi; Equity Analyst; Jefferies LLC, Research Division. Jessica Macomber Fye; Analyst; JPMorgan Chase & Co, Research Division. Justin Reid Zelin; Director & Biotechnology Research Analyst; BTIG, LLC, Research Division. Konstantinos Biliouris; Director & Biotechnology Analyst; BMO Capital Markets Equity Research. Umer Raffat; Senior MD & Senior Analyst of Equity Research; Evercore ISI Institutional Equities, Research Division. Yaron Benjamin Werber; MD & Senior Biotechnology Analyst; TD Cowen, Research Division. Good day, ladies and gentlemen. Thank you for standing by. Welcome to Legend Biotech First Quarter 2024 Finan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q1-2024-legend-biotech-corp-042001306.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435589453","title":"Buy Rating Affirmed for Legend Biotech on CARVYKTI Growth and Positive Clinical Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2435589453","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435589453?lang=en_us&edition=fundamental","pubTime":"2024-05-14 06:56","pubTimestamp":1715641010,"startTime":"0","endTime":"0","summary":"Analyst Justin Zelin of BTIG reiterated a Buy rating on Legend Biotech (LEGN – Research Report), retaining the price target of $91.00. Justin Zelin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-legend-biotech-on-carvykti-growth-and-positive-clinical-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-legend-biotech-on-carvykti-growth-and-positive-clinical-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435304307","title":"William Blair Remains a Hold on Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435304307","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435304307?lang=en_us&edition=fundamental","pubTime":"2024-05-14 03:35","pubTimestamp":1715628919,"startTime":"0","endTime":"0","summary":"In a report released today, Sami Corwin from William Blair maintained a Hold rating on Legend Biotech (LEGN – Research Report). The company’s share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-remains-a-hold-on-legend-biotech-legn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-remains-a-hold-on-legend-biotech-legn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435370183","title":"Legend Biotech Corporation 2024 Q1 - Results - Earnings Call Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2435370183","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435370183?lang=en_us&edition=fundamental","pubTime":"2024-05-14 00:13","pubTimestamp":1715616824,"startTime":"0","endTime":"0","summary":"The following slide deck was published by Legend Biotech Corporation in conjunction with their 2024 Q1 earnings call.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4692811-legend-biotech-corporation-2024-q1-results-earnings-call-presentation","is_publish_highlight":false,"gpt_icon":0},{"id":"2435377591","title":"Amid Biotech Pitfalls, this Stock Has Outperformed NVDA in the Last 3 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2435377591","media":"CoinMarketCap","top":-1,"share":"https://ttm.financial/m/news/2435377591?lang=en_us&edition=fundamental","pubTime":"2024-05-13 23:54","pubTimestamp":1715615662,"startTime":"0","endTime":"0","summary":"Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our website policy prior to making financial decisions. Biotech stocks, especially of s","market":"us","thumbnail":"https://academy-public.coinmarketcap.com/srd-optimized-uploads/895ab18e8a8b4f9886c74ba5a140116c.jpeg","type":0,"news_type":0,"thumbnails":["https://academy-public.coinmarketcap.com/srd-optimized-uploads/895ab18e8a8b4f9886c74ba5a140116c.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/664237b84463b457e78d80a2/","is_publish_highlight":false,"gpt_icon":0},{"id":"2435378404","title":"Legend Biotech Corp reports results for the quarter ended in March - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2435378404","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2435378404?lang=en_us&edition=fundamental","pubTime":"2024-05-13 21:32","pubTimestamp":1715607136,"startTime":"0","endTime":"0","summary":"* Legend Biotech Corp    reported a quarterly adjusted loss of 16 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of -68 cents.  T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435249813","title":"Legend Biotech’s Strong Q1 Growth and Strategic Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2435249813","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435249813?lang=en_us&edition=fundamental","pubTime":"2024-05-13 19:58","pubTimestamp":1715601482,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation (LEGN) has released an update. Legend Biotech Corporation has reported promising first quarter 2024 financial results, w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/legend-biotechs-strong-q1-growth-and-strategic-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/legend-biotechs-strong-q1-growth-and-strategic-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435326426","title":"Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2435326426","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2435326426?lang=en_us&edition=fundamental","pubTime":"2024-05-13 19:21","pubTimestamp":1715599260,"startTime":"0","endTime":"0","summary":"Legend Biotech narrowed its loss in the first quarter as revenue climbed on higher sales of its multiple myeloma treatment Carvykti.The cell therapy company posted a loss of $59.8 million, or 16 cents a share, compared with a loss of $112.1 million, or 34 cents a share, in the same quarter a year ago.Analysts surveyed by FactSet had been expecting 19 cents a share.Revenue climbed to $94 million from $36.3 million in the year-ago quarter. Analysts had been expecting $143.2 million, according to FactSet.License revenue of $12.2 million came in from deferred revenue connected to a license agreement with Novartis Pharma for the development of certain therapies.Collaboration revenue jumped to $78.5 million from $36.3 million, due to higher sales of Carvykti, a treatment for multiple myeloma, in connection with its collaboration and license agreement with Janssen Biotech, a Johnson & Johnson subsidiary.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2435325711","title":"Legend Biotech GAAP EPS of -$0.16 beats by $0.02, revenue of $93.99M misses by $47.37M","url":"https://stock-news.laohu8.com/highlight/detail?id=2435325711","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435325711?lang=en_us&edition=fundamental","pubTime":"2024-05-13 19:04","pubTimestamp":1715598289,"startTime":"0","endTime":"0","summary":"Legend Biotech press release  : Q1  GAAP EPS of -$0.16  beats by $0.02.Cash and cash equivalents, deposits, and short-term investments of $1.3 billion, as of March 31, 2024, which Legend believes will provide financial runway into 2026, when Legend Biotech anticipates achieving an operating profit.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4105028-legend-biotech-gaap-eps-of--016-beats-by-002-revenue-of-9399m-misses-by-4737m","is_publish_highlight":false,"gpt_icon":0},{"id":"2435325923","title":"Legend Biotech Q1 2024 GAAP EPS $(0.16) Beats $(0.34) Estimate, Sales $93.991M Miss $152.631M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2435325923","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2435325923?lang=en_us&edition=fundamental","pubTime":"2024-05-13 19:02","pubTimestamp":1715598135,"startTime":"0","endTime":"0","summary":"Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.34) by 52.94 percent. This is a 52.94 percent increase over losses of $(0.34) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38784525/legend-biotech-q1-2024-gaap-eps-0-16-beats-0-34-estimate-sales-93-991m-miss-152-631m-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2435251326","title":"Legend Biotech Reports First Quarter 2024 Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2435251326","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2435251326?lang=en_us&edition=fundamental","pubTime":"2024-05-13 19:00","pubTimestamp":1715598000,"startTime":"0","endTime":"0","summary":"CARVYKTI  net trade sales of approximately $157 million. EC and US FDA approved CARVYKTI label expansion in earlier lines of treatment for adult patients with relapsed and lenalidomide-refractory multiple myeloma. Legend and Johnson & Johnson enter into Master Manufacturing and Supply Services Agreement with Novartis Pharmaceuticals Corporation. On April 5, Legend Biotech earned a milestone payment of $45 million in connection with FDA’s approval of CARVYKTI’s label expansion to treat 2L+ MM, in accordance with the Janssen Agreement*. Cash and cash equivalents, deposits, and short-term investments of $1.3 billion, as of March 31, 2024, which Legend believes will provide financial runway into 2026, when Legend Biotech anticipates achieving an operating profit. SOMERSET, N.J., May 13, 2024----Legend Biotech Corporation  , a global leader in cell therapy, today reported its first quarter 2024 unaudited financial results and key corporate highlights.The Brazilian Health Regulatory Agency, ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ISStGefXrGCTQAwVuqtqDg--~B/aD0yMTE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ad5b9065b0e422e975c884e32b113db7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ISStGefXrGCTQAwVuqtqDg--~B/aD0yMTE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ad5b9065b0e422e975c884e32b113db7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/legend-biotech-reports-first-quarter-110000971.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legendbiotech.com","stockEarnings":[{"period":"1week","weight":0.0444},{"period":"1month","weight":-0.0752},{"period":"3month","weight":-0.2229},{"period":"6month","weight":-0.3005},{"period":"1year","weight":-0.3449},{"period":"ytd","weight":-0.2495}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Legend Biotech Corp is a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's differentiated technology, global development and manufacturing strategy and expertise provide it with the ability to generate, test and manufacture next-generation cell therapies targeting indications with high unmet needs.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.065278},{"month":2,"riseRate":0.5,"avgChangeRate":0.025486},{"month":3,"riseRate":0.5,"avgChangeRate":-0.027354},{"month":4,"riseRate":0.75,"avgChangeRate":0.086701},{"month":5,"riseRate":0.75,"avgChangeRate":0.081916},{"month":6,"riseRate":1,"avgChangeRate":0.139651},{"month":7,"riseRate":0.5,"avgChangeRate":-0.042708},{"month":8,"riseRate":0,"avgChangeRate":-0.060697},{"month":9,"riseRate":0.25,"avgChangeRate":0.018606},{"month":10,"riseRate":0.5,"avgChangeRate":0.020275},{"month":11,"riseRate":0.5,"avgChangeRate":0.021203},{"month":12,"riseRate":0,"avgChangeRate":-0.047373}],"exchange":"NASDAQ","name":"Legend Biotech","nameEN":"Legend Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Legend Biotech,LEGN,Legend Biotech股票,Legend Biotech股票老虎,Legend Biotech股票老虎国际,Legend Biotech行情,Legend Biotech股票行情,Legend Biotech股价,Legend Biotech股市,Legend Biotech股票价格,Legend Biotech股票交易,Legend Biotech股票购买,Legend Biotech股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction